This strategy successfully induced CXCR4+ macrophages polarization into M1 tumor-suppressive phenotype in a mouse model of triple-negative breast cancer, offering a dual-targeted therapeutic effect [240]. This evidence concerns the gene CXCR4 and neoplasm.